BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
Rehovot, Israel--(Newsfile Corp. - March 31, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 & Subsequent Opera
2025-03-31 4:05 PM EDT
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 after market close on Monday, March 31, 2025. Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Monday, March 31, 2025, to...
2025-03-17 8:30 AM EDT
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 37th Annual Roth Conference taking place on March 16-18, 2025. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the duration of the event. 37th Annual Roth Conference...
2025-03-06 8:30 AM EST
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced new 'in vitro' test results for the Company's proprietary new Olive Cell compound, which showed reduced fat accumulation in human liver cells. Fat accumulation in the liver is a leading cause of non-alcohol fatty liver disease (NAFLD), which affects...
2025-03-04 8:30 AM EST
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 18, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that its Red Grape Cell composition - known commercially as VINIA® - has now exceeded $50 Million USD in cumulative sales with the vast majority of sales occurring since launching in the US less than 4 years ago. VINIA®, a red grape cell-based...
2025-02-18 8:30 AM EST
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the WeBull Consumer Stocks Virtual Webinar taking place on February 18, 2025. CEO Ilan Sobel is scheduled to present at the event. Following the webinar, a replay link to the...
2025-02-12 8:30 AM EST
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
British Columbia and Rehovot, Israel--(Newsfile Corp. - January 22, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that Mr. Sharon Malka has agreed to serve as an independent director of BioHarvest. The appointment is effective immediately. "We are very pleased to announce the addition of Mr. Malka to the BioHarvest Board of Directors," said Dr....
2025-01-22 8:30 AM EST
BioHarvest Issues Shareholder Letter and Provides Corporate Update
British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2024 can be summarized as a year of transformation and growth for BioHarvest, where we introduced our new CDMO Services division -...
2025-01-08 8:41 AM EST
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Tate & Lyle PLC ('Tate & Lyle'), a world leader in ingredient solutions for healthier and tastier food and beverages, and BioHarvest Sciences (NASDAQ: BHST) (CSE: BHSC) ('BioHarvest'), leaders in Botanical Synthesis, announce a pioneering new partnership to develop the next-generation of proprietary plant-based molecules to address increasing consumer desire for affordable, nutritious and more sustainable...
2024-12-11 6:00 AM EST
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the third quarter ended September 30, 2024. Third Quarter & Subsequent 2024 Operational Highlights All figures stated in this news release are in U.S. dollars unless stated otherwise. Total...
2024-11-25 4:05 PM EST
BioHarvest Launches VINIA SuperFood Functional Tea Line
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced the launch of its highly anticipated VINIA® infused teas - a line of SuperFood functional teas that deliver the same clinically validated benefits as the successful VINIA® supplements. This launch further demonstrates the potential...
2024-11-25 8:30 AM EST
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December 3, 2024. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional...
2024-11-21 8:30 AM EST
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 18, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2024 after market close on Monday, November 25, 2024. Management will host an investor conference call at 4:30 p.m. Eastern time on Monday, November 25,...
2024-11-18 8:30 AM EST
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's shares will begin trading on the Nasdaq Global Market ("Nasdaq") at the opening of the U.S. market today under the new ticker symbol "BHST". The Company's common shares will continue to trade on the Canadian Securities...
2024-11-12 8:30 AM EST
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Nasdaq Stock Market LLC has approved the listing of the Company's common shares on the Nasdaq Global Market ("Nasdaq"). The Company expects to begin trading on the Nasdaq on Tuesday, November 12th, 2024, under the new symbol "BHST". The...
2024-11-07 8:30 AM EST
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today preannounced preliminary financial results for the three months ended September 30, 2024. The Company anticipates record revenue of at least $6.5 million in the third quarter of 2024, which represents a 100% increase from the third quarter of 2023. The...
2024-10-23 8:30 AM EDT
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that management has been invited to attend the LD Micro Main Event XVII Conference taking place on October 30, 2024. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event, and will host a...
2024-10-16 8:47 AM EDT
BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company's management team, continuing to serve as Vice President of Investor Relations of the Company. Mr. Ryan resigned as a director of the Company in order for the Company to meet Nasdaq mandates to have a majority of...
2024-09-20 8:30 AM EDT
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024. CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and...
2024-09-12 8:30 AM EDT
BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City. Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with...
2024-09-04 8:30 AM EDT